Drugs & 
Pill 
Interaction 
Side 
Conditions 
Treatment 
Compare 
My Med 
Discount 
FDA 
Price 
Phonetic 
Health Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
FDA Approves Anktiva (nogapendekin alfa inbakicept-pmln) Plus BCG for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
ImmunityBio, Inc. (NASDAQ: IBRX), an immunotherapy company, today announced that the U.S. Food and Drug Administration (FDA) has approved Anktiva...
U.S. FDA Approves Subcutaneous Administration of Takeda’s Entyvio (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
OSAKA, Japan April 19, 2024 and CAMBRIDGE, Massachusetts, April 18, 2024 – Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug...
FDA Approves Lumisight (pegulicianine) Optical Imaging Agent to Illuminate Residual Breast Cancer Post-Lumpectomy
(BUSINESS WIRE) April 18, 2024 --Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging technologies for...
FDA Approves Genentech's Alecensa as First Adjuvant Treatment for People With ALK-Positive Early-Stage Lung Cancer
April 18, 2024 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration...
FDA Approves Selarsdi (ustekinumab-aekn), a Biosimilar to Stelara
(BUSINESS WIRE) April 16, 2024 --Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE:...
Few Cancer Survivors Fully Adherent to ACS Nutrition and Physical Activity Guidelines
Only 4 percent of cancer survivors are fully adherent to current American Cancer Society (ACS) nutrition and physical activity guidelines, according to...
Antihypertensive Meds Initiation Linked to Fractures in Nursing Home Seniors
For longer-term nursing home residents, initiation of antihypertensive medication is associated with an increased risk for fractures and falls, according...
Higher Dietary Quality at Breast Cancer Diagnosis Linked to Lower CVD Risk
Higher diet quality at diagnosis of breast cancer is associated with a lower risk for cardiovascular disease (CVD) events and death, especially the Dietary...
Structured Seizure Action Plan Beneficial for Adults With Epilepsy
Implementing a structured seizure action plan (SAP) in an adult epilepsy center increases provider utilization and is associated with increased patient...
Cancer Takes Tough Toll on Family Finances
About six out of 10 working-age adults hit with a cancer diagnosis say it put real pressure on their financial survival, a new report finds. “Today’s...
Stick to Heimlich Maneuver Not 'Anti-Choking' Devices, FDA Says
People should rely on the well-established Heimlich maneuver to save a choking victim, rather than newfangled “anti-choking” devices, the U.S. Food...
Women in the Military at Risk for Low-Weight Babies
Active military service appears to increase a woman’s risk of having a low birthweight baby, a new review finds.Nearly two-thirds of studies (63%) conclude...
Repeat Blasts Can Damage Soldiers' Brains, Study Confirms
Soldiers can suffer brain injury if they are repeatedly exposed to explosive blasts, a new study shows.Further, the more frequently a soldier is exposed...
FDA Approves Clinical Trial for GFH925 Monotherapy in Phase III Registrational Study Treating Metastatic Colorectal Cancer
SHANGHAI, April 19, 2024. GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology,...
Abeona Therapeutics Provides Regulatory Update on Pz-cel
Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced a regulatory update for prademagene zamikeracel (pz-cel). The U.S. Food and Drug Administration...
Doctors Underutilize Next-Gen Antibiotics to Fight Resistant Infections in U.S. Hospitals
Despite Food and Drug Administration (FDA)-approval of seven next-generation antibiotics to fight infections caused by resistant “gram-negative”...
Many Seniors Are Overmedicated, But ChatGPT Might Prevent That
AI could help doctors cut back on the bewildering variety of medications that seniors frequently are prescribed, a new study suggests. More than 40% of...
FDA Requires Boxed Warning for T Cell Malignancies Following Treatment with BCMA-Directed or CD19-Directed Autologous CAR T Cell Immunotherapies
In November 2023, the Food and Drug Administration (FDA) posted a safety communication to provide information about reports of T cell malignancies including...
Recently Added
Recently added consumer and prescribing information: Xromi, Risvan, Voydeya, Winrevair, Pemgarda, Tryvio, Edurant and Edurant Ped, Tevimbra, Rezdiffra, Tyenne
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex Carenotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Anktiva Anktiva (nogapendekin alfa inbakicept-pmln) is a first-in-class interleukin-15 (IL-15) superagonist for use in combination with Bacillus...
- Lumisight Lumisight (pegulicianine) is an optical imaging agent for the detection of residual cancerous tissue during breast cancer surgery.
- Selarsdi Selarsdi (ustekinumab-aekn) is a human interleukin-12 and -23 antagonist biosimilar to Stelara used for the treatment of plaque psoriasis...
Drugs in Development (Not yet approved)
- Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...
- Libervant Libervant (diazepam) is a buccal film formulation of the approved benzodiazepine diazepam in development for the management of seizure clusters.
Drug Information
Tools
- Interaction Checker
- Pill Identifier
- Symptom Checker
- Medication Record
- Mobile Apps
- Drug Imprint Codes
- Community Support
- Compare Drugs
News & Alerts
- Medical News
- Clinical Trial Results
- FDA Drug Alerts
- FDA Consumer Updates
- New FDA Approvals
- New Drug Applications
- Drug Shortages
- Video Center
- Popular Articles
Professionals
Top 100 Drugs
- Abilify
- Acetaminophen
- Adderall
- Alprazolam
- Amantadine
- Ambien
- Amitriptyline
- Amlodipine
- Amoxicillin
- Ativan
- Atorvastatin
- Avastin
- Azithromycin
- Baclofen
- Belsomra
- Benadryl
- Benzonatate
- Biktarvy
- Botox
- Brilinta
- Bunavail
- Buprenorphine
- Bupropion
- Buspirone
- Cephalexin
- Cetirizine
- Ciprofloxacin
- Citalopram
- Clindamycin
- Clonazepam
- Clonidine
- Cosentyx
- Cyclobenzaprine
- Cymbalta
- Dexamethasone
- Diazepam
- Diclofenac
- Doxycycline
- Duloxetine
- Dupixent
- Eliquis
- Enbrel
- Entyvio
- Epclusa
- Ezetimibe
- Famotidine
- Farxiga
- Fluoxetine
- Furosemide
- Gabapentin
- Humira
- Hydrochlorothiazide
- Hydrocodone
- Hydroxyzine
- Ibuprofen
- Januvia
- Jardiance
- Keytruda
- Klonopin
- Levothyroxine
- Lexapro
- Lisinopril
- Loratadine
- Lorazepam
- Losartan
- Lyrica
- Meloxicam
- Metformin
- Methadone
- Methocarbamol
- Methotrexate
- Metoprolol
- Metronidazole
- Miralax
- Mirtazapine
- Mounjaro
- Mucinex
- Naloxone
- Naltrexone
- Naproxen
- Omeprazole
- Opdivo
- Ondansetron
- Otezla
- Oxycodone
- Ozempic
- Pantoprazole
- Penicillin
- Percocet
- Phentermine
- Plan B
- Praluent
- Prednisone
- Prolia
- Promethazine
- Propranolol
- Prozac
- Qulipta
- Repatha
- Restasis
- Rexulti
- Rytary
- Seroquel
- Sertraline
- Sildenafil
- Sinemet
- Skyrizi
- Spironolactone
- Stelara
- Sublocade
- Suboxone
- Subutex
- Taltz
- Tamsulosin
- Tizanidine
- Toradol
- Toujeo
- Tramadol
- Trazodone
- Trelegy
- Trintellix
- Tylenol
- Ubrelvy
- Valium
- Vascepa
- Venlafaxine
- Verzenio
- Viagra
- Vivitrol
- Vraylar
- Vyvanse
- Wellbutrin
- Xanax
- Xolair
- Zetia
- Zoloft
- Zyrtec
